VRPX(Delisted)
VirpaxยทNASDAQ
--
--(--)
VRPX Profile
Virpax Pharmaceuticals, Inc.
A company specializing in developing non-addictive products for pain management, post-traumatic stress disorder, central nervous system (CNS) disorders and viral barrier indications
1055 Westlakes Drive, Suite 300, Berwyn, PA 19312
--
Virpax Pharmaceuticals, Inc., was incorporated in Delaware on May 12, 2017. The Company is a preclinical stage pharmaceutical company focused on developing novel proprietary drug delivery systems across various pain indications to enhance adherence and optimize each product candidate under development. The Company's drug delivery systems and drug release technologies under development focus on advancing non-opioid and non-addictive pain management treatments and the treatment of central nervous system (" CNS ") diseases to improve the quality of life of patients.
